Multistakeholder Engagement in Biosimilar Polic...

By João L. Carapinha

June 3, 2026

In advancing biosimilar policy development across Europe, the AUGMENT Biosimilars project identifies effective measures to overcome barriers to uptake, lower costs, and expand patient access to follow-on biological medicines. The three-day